Science and technology companies operate in uncertainty.
Innovative companies rarely follow a straight line.
Development plans change. Timelines move. Technical risk evolves. Funding conditions shift.
For founders, management teams, boards and investors, the challenge is not simply whether the science or technology is promising.
The challenge is whether the business can explain:
- what progress means
- what milestones matter
- how much funding is required
- how long the runway lasts
- what risks could change the plan
- why the financial logic is credible
Strong technology is important.
But investors fund progress, execution and credibility.
The problem is translation.
Scientific and technical plans often contain uncertainty.
That uncertainty has financial consequences, including cash runway, hiring plans, operational priorities and future funding requirements.
Integral helps companies understand those consequences and communicate them clearly.
You are the scientific expert.
Our role is to understand the financial implications of scientific and technical uncertainty and translate them into financial, operational and fundraising decisions.
The outcome
- A clearer understanding of what matters.
- A stronger funding story.
- Better strategic and operating decisions.
- Greater investor confidence.